🔎 Trials Near Me

መነሻ › ግሊዎማ › Texas › Houston

በHouston፣ TX ለግሊዎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለግሊዎማ የሚደረጉ 23 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Houston
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05417594

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
12 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05099003

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • M D Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT03896568

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Baylor College of Medicine, Houston
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04094610

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06838676

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

ተሳታዮችን በመፈለግ ላይ
  • M D Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT04373720

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • M D Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT04771806

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
36 Months · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Texas Children's Hospital, Houston
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Texas Children's Hospital, Houston
እድሜ ከ12 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Texas Children's Hospital, Houston
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05096481

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • M D Anderson Cancer Center, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT01772771

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Excel Diagnostics & Nuclear Oncology Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT07733674

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Texas Children's Hospital, Houston
12 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT04099797

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ 8 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
  • Texas Children's Hospital, Houston
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT06333899

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
  • M D Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT05804227

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT05843253

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT06326411

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
  • Texas Children's Hospital, Houston
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT04655404

በሌሎች ከተሞች ለግሊዎማ የሚደረጉ ጥናቶች

በHouston ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።